Cabot Undervalued Stocks Advisor Special Bulletin
With the shares continuing to surge past our recently raised 65 price target, and now being priced at a premium to even our upgraded valuation metrics
Read More
With the shares continuing to surge past our recently raised 65 price target, and now being priced at a premium to even our upgraded valuation metrics
Read More
2021 Kicks Off With a Bang
A funny thing happened while I was preparing this issue yesterday. Not funny ha-ha. Funny odd.
I was updating my performance tables and noticed that the performance of the Marijuana Index year-to-date was exactly the same as its performance all...
Read More
The Point of Peak Perception?
It’s a truism of investing that stocks bottom when the news is terrible and pessimism and fear are the prevailing sentiments—but peak when the news is good and optimism and greed reign.
You have only to look back to March a..
Read More
The Future is Full of Surprises
One of the oft-told tales of the California Gold Rush is that while most miners failed to strike it rich, the real money-makers were the people selling shovels—and of course that immigrant from Bavaria, Levi Strauss, who sold denim...
Read More
Bruce is selling three portfolio stocks.
Read More
We're selling this portfolio stock with a 54% profit since its December 2019 recommendation.
Read More
Investing in a World of Uncertainty
“You can only see as far as your headlights … but you can make the whole trip that way.” E.L. Doctorow
Short-term, the world is full of uncertainty today, with a major election around the corner and a pandemic to...
Read More
Chart is an interesting company, for sure, and we would be happy to buy again at much lower prices.
Read More
Still Cautious
Seven weeks ago I started recommending selling marijuana stocks and taking profits, saying that they’d gone too high and that investment sentiment seemed equally high as well (a bad thing). Since then, the Marijuana Index is down 10% and the Alternative Harvest is...
Read More
It pays to invest in companies that avoid taxes the way Donald Trump has for years. For evidence, look no further than P10 Holdings (PIOE).
Read More
A Little Cautious
The good news is that our portfolio is well in the black for the year, thanks to strong performances by all four of our U.S. multi-state operators, our REIT (IIPR) and our hydroponics retailer (GRWG). (Readers who held GRWG before second-quarter were...
Read More
Back in the Black
The broad market is strong, but the marijuana sector is even stronger, with six of our stocks hitting new recovery highs this week, and another hitting an all-time high last week!
The reasons for this strength are numerous.
First, after a two-year market...
Read More
Buying Opportunities
The last few weeks have brought a much-needed market correction—much-needed because after advancing for eleven weeks from the COVID-19 bottom, the market was extended, and some segments of the investing world were positively giddy. But now that the correction has done its capped...
Read More
Yesterday, after the market closed, rumors emerged that this portfolio stock is once again in talks to sell their gas stations.
Read More
This portfolio stock reported good second-quarter results and moves from Hold to Buy.
Read More
The S&P 500 has had a tremendous run-up. It’s due for a correction, although it’s not yet indicating that the correction is imminent. Be cautious. Use stop-loss orders and/or pare back positions on stocks that have retraced early 2020 highs.
Read More
Crista updates three portfolio stocks and has one rating change.
Read More
The Trend Strengthens!
Canada was first, but the U.S. will dominate. That’s not exactly a surprise, but the evidence is now piling up, most recently in the form of some terrific first quarter reports by U.S. marijuana companies while the Canadians continue to cut and...
Read More
The S&P 500 and Dow Jones stock indexes appear to have tentatively begun rising above a trading range that lasted for six weeks.
Read More
Crista updates us on two stocks, one in the portfolio and one that she has recommended in the past year.
Read More